The pause issued by Alito will last until at least May 11, according to The Times, when the full court will then determine how to move forward. HealthDay News — US Supreme Court Justice Samuel Alito ...

Real-time continuous glucose monitoring (CGM) improves blood glucose management in adults with type 2 diabetes managed with basal insulin, according to a study ...

Tazbentetol is an investigational, once-daily synaptic regenerative therapy designed to restore cognitive and motor function in ALS.

Topline data from the ACACIA-HCM study reveal that the cardiac myosin inhibitor aficamten met all primary and key secondary endpoints, offering a potential new treatment pathway for patients with ...

About one-quarter of large outbreak-related cases ID'd through contact tracing; they less often had clinical markers of highly infectious disease ...

A larger percentage of patients in PFA group had treatment success at 12 months compared with those receiving antiarrhythmic-drug therapy.

Vaccinations administered alone or sequentially are safe and effective, providing high RSV-A, -B nAb titers in infants ...

The approval is supported by bioequivalence data assessing the once-daily extended-release formulation to twice-daily immediate-release ruxolitinib in healthy participants.

AASM recommends against use of combination of CBT-I plus medication over CBT-I alone for chronic insomnia disorder.

Clinical data from a 16-patient pediatric study demonstrate the safety and efficacy of Asceniv in younger populations, ...

Nereus ™ (tradipitant) is now available for the prevention of vomiting induced by motion in adults. According to manufacturer Vanda Pharmaceuticals, the product is available by ...

Patients treated with dilanubicel demonstrated faster hematopoietic recovery and had a markedly lower incidence of severe acute GVHD. HealthDay News — Adding dilanubicel, a cryopreserved, cord blood ...